Form 8-K Celularity Inc For: Apr 09

Go back to Form 8-K Celularity Inc For: Apr 09

Celularity amends deal terms with NexGel, sets $13.3 million consideration

April 21, 2026 9:08 AM EDT

Celularity Inc. (NASDAQ: CELU) entered into an amendment to its asset purchase and exclusive license agreement with NexGel Inc., according to a company statement. The amendment modifies the original agreement dated March 6, 2026.

Under the revised terms, the total consideration payable to Celularity is... More